Literature DB >> 31649130

Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.

Robert O Opoka1, Heather A Hume1,2, Teresa S Latham3, Adam Lane3,4, Olatundun Williams5, Jennifer Tymon6, Maria Nakafeero3,7, Phillip Kasirye1, Christopher M Ndugwa1, Chandy C John8, Russell E Ware9,4,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31649130      PMCID： PMC7271570          DOI： 10.3324/haematol.2019.231407

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.

Authors:  Léon Tshilolo; George Tomlinson; Thomas N Williams; Brígida Santos; Peter Olupot-Olupot; Adam Lane; Banu Aygun; Susan E Stuber; Teresa S Latham; Patrick T McGann; Russell E Ware
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

2.  Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research.

Authors:  Patrick T McGann; Arielle G Hernandez; Russell E Ware
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

Review 3.  Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

Authors:  Amrana Qureshi; Banu Kaya; Shivan Pancham; Russell Keenan; Jeremy Anderson; Magbor Akanni; Jo Howard
Journal:  Br J Haematol       Date:  2018-05-06       Impact factor: 6.998

4.  Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study.

Authors:  Madu Anazoeze Jude; Galadanci Najiba Aliyu; Aisha Mohammed Nalado; Kangiwa Umar Garba; Fowodu O Florence; Ahmed Hassan; Marcus Inyama; Oluwaseun Akinpelu; Nwagha Theresa; Ibegbulam Obike Godswill; Ocheni Sunday; Emodi Ifeoma; Ikefuna Anthony; Chukwu Batholomew; Okocha E Chide; Orkuma Joseph; Iheanacho Malachy; Kaladada Korubo; Anike Uchenna Sabastine; Agu Kingsley; Charles Nonyelu; Angela Ugwu; Augustin Duru; Chukwudi Anigbo; Alozie Eze; Awele Chukwurah; Uchenna Ololo; Caroline Omoti; Obineche Agwu; Okpala Iheanyi
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

5.  The use of transcranial ultrasonography to predict stroke in sickle cell disease.

Authors:  R Adams; V McKie; F Nichols; E Carl; D L Zhang; K McKie; R Figueroa; M Litaker; W Thompson; D Hess
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

Review 6.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

7.  Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.

Authors:  Robert O Opoka; Christopher M Ndugwa; Teresa S Latham; Adam Lane; Heather A Hume; Phillip Kasirye; James S Hodges; Russell E Ware; Chandy C John
Journal:  Blood       Date:  2017-10-19       Impact factor: 22.113

8.  Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Authors:  Sherri A Zimmerman; William H Schultz; Shelly Burgett; Nicole A Mortier; Russell E Ware
Journal:  Blood       Date:  2007-04-11       Impact factor: 22.113

9.  Prevalence of stroke in children admitted with sickle cell anaemia to Mulago Hospital.

Authors:  Deogratias Munube; Elly Katabira; Grace Ndeezi; Moses Joloba; Samden Lhatoo; Martha Sajatovic; James K Tumwine
Journal:  BMC Neurol       Date:  2016-09-17       Impact factor: 2.474

10.  Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial.

Authors:  Juliana N Anyanwu; Olatundun Williams; Casey L Sautter; Phillip Kasirye; Heather Hume; Robert O Opoka; Teresa Latham; Christopher Ndugwa; Russell E Ware; Chandy C John
Journal:  JMIR Res Protoc       Date:  2016-06-23
View more
  5 in total

1.  Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.

Authors:  Richard Idro; Amelia K Boehme; Michael Kawooya; Samson K Lubowa; Deogratias Munube; Paul Bangirana; Robert Opoka; Ezekiel Mupere; Angela Lignelli; Philip Kasirye; Nancy S Green; Frank J Minja
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-02-11       Impact factor: 2.136

Review 2.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Angela E Rankine-Mullings; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

Review 3.  Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease.

Authors:  Thamal Darshana; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

4.  Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Fouad Madhi; Camille Jung; Ralph Epaud; Suzanne Verlhac
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

Review 5.  Effective use of hydroxyurea for sickle cell anemia in low-resource countries.

Authors:  Alexandra Power-Hays; Russell E Ware
Journal:  Curr Opin Hematol       Date:  2020-05       Impact factor: 3.218
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.